4Anderson H,Lund B,Bach F. Single-agent activity of weekly gemcitabine in advanced non-smal-celllung cancer:a phase II study[J].{H}Journal of Clinical Oncology,1994,(09):1821-1826.
5Monnet I,Brienza S,Hugret F. Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer(NSCLC)[J].{H}EUROPEAN JOURNAL OF CANCER,1998,(07):1124-1127.
6Bidoli P,Zilembo N,Cortinovis D. Randomized phase II three-arm trial with three platinum-based dou-blets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study[J].{H}ANNALS OF ONCOLOGY,2007,(03):461-467.
7Egger M,Smith GD,Schneider M. Bias in me-ta-analysis detected by a simple,graphical test[J].{H}British Medical Journal,1997,(7109):629-634.
8Louafi S,Boige V,Ducreux M. Gemcitabine plus oxaliplatin(GEMOX)in patients with advanced hepa-tocellular carcinoma(HCC)[J].{H}CANCER,2007,(07):1384-1390.